RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
#Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis @Crit_Care | #ECM https://t.co/QtCbaV56SV
"Low-dose corticosteroid treatment was associated with reduced risk of in-hospital death within 60 days in COVID-19 patients who developed ARDS." #PharmICU #TwitteRx https://t.co/0qZFeLE720
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
RT @Crit_Care: #CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOA…
#CritCare #OpenAccess The controversial use of #corticosteroids in #COVID_19 patients https://t.co/UUpXwvd1Q1 #FOAMed #FOAMcc #BMC #ICU #pneumonia #ARDS #Sars_CoV_2 #Methylprednisolone #epidemics @jlvincen @ISICEM https://t.co/jb9MTRVkVk
1,656/ China (adult smoking rate was 26.6% in 2018) Of 382 patients hospitalized with Covid-19 ARDS, 9.2% had a smoking history https://t.co/HXDLNl87TR
RT @ProfAnestesista: #Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with…
#Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis @Crit_Care | #ECM https://t.co/QtCbaV56SV
#Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis @Crit_Care | #ECM https://t.co/gy0RryhMxe
https://t.co/rDtkrkvPkn COVID19に対するステロイドの有効性を調べた後ろ向き研究 結果は、交絡因子調整後、ステロイド群で60日死亡率が減少した(HR:0.42[0.21-0.85]) #当麻_感染